THE IMPACT OF THE APOLIPOPROTEIN E POLYMORPHISM ON THE LIPOPROTEIN PROFILE IN INSULIN-DEPENDENT DIABETES - THE PITTSBURGH EPIDEMIOLOGY OF DIABETES COMPLICATIONS STUDY .9.

被引:18
作者
EICHNER, JE
FERRELL, RE
KAMBOH, MI
KULLER, LH
BECKER, DJ
DRASH, AL
STEIN, EA
ORCHARD, TJ
机构
[1] UNIV PITTSBURGH, DEPT EPIDEMIOL, PITTSBURGH, PA 15260 USA
[2] UNIV PITTSBURGH, DEPT GENET, PITTSBURGH, PA 15260 USA
[3] CHILDRENS HOSP, DEPT PEDIAT ENDOCRINOL, PITTSBURGH, PA 15213 USA
[4] UNIV CINCINNATI, MED CTR, CINCINNATI, OH 45267 USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1992年 / 41卷 / 04期
关键词
D O I
10.1016/0026-0495(92)90066-J
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The apolipoprotein (apo) E polymorphism has been related to differences in lipoprotein metabolism and lipid/lipoprotein concentrations in a number of studies. Whether these associations are seen in insulin-dependent diabetes mellitus (IDDM), which itself affects many of the same aspects of lipoprotein metabolism as does the apo E polymorphism, is unknown. The present study is an investigation into the influence of apo E phenotype on lipoprotein concentrations in a large group of IDDM patients (n = 433) participating in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study. The frequency of the three apo E alleles 2, 3, and 4 did not differ in this population from that reported in general white populations. Although the diabetic subjects show the same trends as seen in the general population, ie, apo E-2 is associated with lower and apo E-4 with higher low-density lipoprotein cholesterol (LDLc) compared with apo E3 (P< .03), they also show relationships with glycemic control that influence the relative levels of lipid measures with respect to apo E phenotype. Results also raise the possibility that lipoprotein composition varies according to apo E phenotype in IDDM. © 1992.
引用
收藏
页码:347 / 351
页数:5
相关论文
共 22 条
[11]  
Jackson R. L., 1983, ENZYMES, V16, P141
[12]  
KAMBOH MI, 1988, J LIPID RES, V29, P1535
[13]  
LOPESVIRELLA MF, 1981, DIABETOLOGIA, V21, P216, DOI 10.1007/BF00252657
[14]   INVIVO STIMULATION OF LOW-DENSITY LIPOPROTEIN DEGRADATION BY INSULIN [J].
MAZZONE, T ;
FOSTER, D ;
CHAIT, A .
DIABETES, 1984, 33 (04) :333-338
[15]  
MENDOZA SG, 1983, ARTERY, V12, P1
[16]   FACTORS ASSOCIATED WITH AVOIDANCE OF SEVERE COMPLICATIONS AFTER 25 YR OF IDDM PITTSBURGH EPIDEMIOLOGY OF DIABETES COMPLICATIONS STUDY .1. [J].
ORCHARD, TJ ;
DORMAN, JS ;
MASER, RE ;
BECKER, DJ ;
ELLIS, D ;
LAPORTE, RE ;
KULLER, LH ;
WOLFSON, SK ;
DRASH, AL .
DIABETES CARE, 1990, 13 (07) :741-747
[17]  
ORCHARD TJ, 1990, ENDOCRINOL METAB, P361
[18]   APOLIPOPROTEIN-E POLYMORPHISM IN THE NETHERLANDS AND ITS EFFECT ON PLASMA-LIPID AND APOLIPOPROTEIN LEVELS [J].
SMIT, M ;
DEKNIJFF, P ;
ROSSENEU, M ;
BURY, J ;
KLASEN, E ;
FRANTS, R ;
HAVEKES, L .
HUMAN GENETICS, 1988, 80 (03) :287-292
[19]  
STEIN EA, 1983, NIH831266 US DEP HLT, P319
[20]  
WARNICK GR, 1978, CLIN CHEM, V24, P900